Search Results - "Gomez-Roca, C."

A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics, and pharmacodynamics of OSE-279, an anti-PD-1 monoclonal antibody in patients with advanced solid tumours.

Authors: Robert M Kotecki N Gomez-Roca C et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 03; Vol. 240, pp. 116729. Date of Electronic Publication: 2026 Apr 09.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

AUTHOR INDEX.

Source: Asia Pacific Journal of Clinical Oncology. Nov2017 Supplement S5, Vol. 13, p225-235. 11p.

Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial.

Authors: Morisseau M Gomez-Roca C Viala M et al.

Source: Investigational new drugs [Invest New Drugs] 2024 Dec; Vol. 42 (6), pp. 664-674. Date of Electronic Publication: 2024 Nov 04.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Signalomics for molecular tumor boards and precision oncology of breast and gynecological cancers.

Authors: Denisenko, Tatiana V Ivanova, Anna E Koval, Alexey et al.

Source: Molecular Systems Biology. Aug2025, Vol. 21 Issue 8, p952-959. 8p.

Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer.

Authors: Hirayama, Aoi Tanaka, Tomohiro Ohishi, Tomokazu et al.

Source: Cells (2073-4409). Dec2025, Vol. 14 Issue 23, p1873. 14p.

The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: A systematic review and meta-analysis.

Authors: Adrianto, Albertus Ari Riwanto, Ignatius Sadhana, Udadi et al.

Source: PLoS ONE. 11/14/2025, Vol. 20 Issue 11, p1-19. 19p.

Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic review.

Authors: Xu J Ni C Qin L et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Apr 10. Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo.

Authors: Ling, Zhiming Wang, Yi Wu, Geping et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 8, p3554. 22p.

Molecular and Cellular Basis of Oral Lichen Planus: Bridging Pathogenesis and Modern Clinical Paradigms.

Authors: Kumagai, Kenichi Kishi, Yuta Suzuki, Taiki et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 8, p3444. 11p.

Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study.

Authors: Facheris, Giorgio Bruni, Alessio Nardone, Valerio et al.

Source: Biomolecules (2218-273X). Mar2026, Vol. 16 Issue 3, p423. 16p.

Pre-Existing Immunity Shapes Cancer Immunotherapy Efficacy.

Authors: Xagara, Anastasia Koinis, Filippos Tsapakidis, Konstantinos et al.

Source: Onco. Mar2026, Vol. 6 Issue 1, p4. 14p.

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial.

Authors: Chen, Xinni Wang, Feng Cheng, Yuan et al.

Source: Clinical & Translational Discovery. Feb2026, Vol. 6 Issue 1, p1-11. 11p.

Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case Report.

Authors: Komuta, Kiyohide Kunimasa, Kei Miyazaki, Akito et al.

Source: Case Reports in Oncology. 2025, Vol. 18 Issue 1, p451-456. 6p.

NUT carcinoma of larynx with aberrant LCA expression: A rare entity with diagnostic and therapeutic challenge.

Authors: Arora, Vikas Pasricha, Sunil Kumar, Ankur et al.

Source: Journal of Cancer Research & Therapeutics. Jan-Mar2025, Vol. 21 Issue 1, p311-314. 4p.

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.

Authors: Wang, Qian Xu, Chunwei Wang, Wenxian et al.

Source: Thoracic Cancer. Sep2023, Vol. 14 Issue 26, p2715-2731. 17p.

A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review.

Authors: Poumeaud F Jaffrelot M Gomez-Roca C et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2024 Jul 30; Vol. 11, pp. 1402902. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.

Authors: Borcoman E Cabarrou B Francisco M et al.

Source: Nature cancer [Nat Cancer] 2025 Aug; Vol. 6 (8), pp. 1370-1383. Date of Electronic Publication: 2025 Jun 30.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

THBS3 Functions as a Novel Biomarker for Prognosis and Immunotherapeutic Response in Colorectal Cancer: An Integrative Analysis and Validation of the Thrombospondin Gene Family.

Authors: Jiang, Tao Zhu, Sichao Zhou, Hengyi et al.

Source: Cancer Informatics. 1/27/2026, Vol. 25, p1-16. 16p.

Tumor Growth Rate Predicts Pathological Outcomes in Breast Fibroepithelial Tumors: A Pilot Study and Review of Literature.

Authors: Bahmad, Hisham F. Falcon, Adriana Araji, Abdallah et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p269. 16p.

Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15 , 3448.

Authors: Hassel, Jessica C. Zimmer, Lisa Sickmann, Thomas et al.

Source: Cancers. Dec2025, Vol. 17 Issue 23, p3726. 13p.